Skip to main content
Equibles

PRASOLCHEM · Prasol Chemicals Limited

Use PRASOLCHEM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PRASOLCHEM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
796.95 INR -30.20 (-3.65%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 23.8K Avg daily vol (41 sessions) 53.52K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close796.95 INR Open827.15 INR Day764.40–847.65 INR Available close range672.05–884.20 INR Avg vol 30d25K Last earningsNov 3, 2026 DataSep 2026–Nov 2026

The closing range uses available history since Sep 16, 2026; less than a full year is stored.

Latest documents

2026
Nov 3
Earnings call
Q2 revenue hits record INR413 crores

Prasol Chemicals reported Q2 FY27 revenue of INR413 crores, up 38.6%, and H1 FY27 EBITDA of INR148 crores, up 106%; FY27 guidance remains INR1,550 to INR1,650 crores revenue and INR240 to INR250 crores EBITDA.

3 source passages
I am very happy to announce that this has been one of our best Q2 of Prasol ever. Generally, we see that Q2 is slightly softer than Q1, and Q4 is generally the best of all the quarters. We have delivered a record quarterly revenue of INR413 crores, registering a year-toyear growth of around 38.6%. EBITDA for the first half was INR148 crores, a year-over-year growth of 106%, translating to an EBITDA margin of 17.5%. We remain on track for our '27 guidelines of a revenue which I am repeating in the range of INR1,550 to INR1,650 crores, EBITDA of INR240 to INR250 crores, approximately 70% to 75% EBITDA growth year-on-year as compared to last year. Open the document at this passage
Sep 29
Earnings call
Q1 2027 earnings call

Prasol Chemicals reported Q1 FY27 revenue of INR433.6 crores, up 35.7% year-on-year, EBITDA of INR90.3 crores, up 122.4%, and PAT of INR61 crores, up 151%; FY27 guidance is INR1,550 crores to INR1,650 crores revenue and INR240 crores to INR250 crores EBITDA.

Read from the first part of this long document
All documents

Quarterly results

Revenue Net income Net loss
· 4.34B INR 610.23M INR '27 Q1 LATEST · 4.13B INR 379.75M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its available closing range
Range low 672.05 INR Now 796.95 INR · 59% Range high 884.20 INR

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:PRASOLCHEM +3.4% +7.7% — -1.0% —

Exchange listing

Market
XBOM
Ticker
PRASOLCHEM
ISIN
INE455U01024
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.prasolchem.com/
Investor relations
https://www.prasolchem.com/investor-relations/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-03 Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-09-29 Transcript
    Earnings Call